We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
(-31%)
Cap. Flow
-$42.6M
Cap. Flow
% of AUM
-48.9%
Top 10 Holdings %
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202
Top Buys
| 1 |
Constellation Brands
STZ
|
+$3.18M |
| 2 |
JPMorgan Chase
JPM
|
+$3.16M |
| 3 |
General Mills
GIS
|
+$2.29M |
| 4 |
Gilead Sciences
GILD
|
+$2.29M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$4.04M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.96M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$2.56M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$2.03M |
| 5 |
Humana
HUM
|
+$1.77M |
Sector Composition
| 1 | Healthcare | 44.7% |
| 2 | Consumer Staples | 14.06% |
| 3 | Consumer Discretionary | 4.38% |
| 4 | Financials | 4.11% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
CALL
Yelp
YELP
$1.51B
| $68K | 0.08% |
59,100
+38,100
| +181% | +$1.41M |
|
|
BIG
127
PUT
DELISTED
Big Lots, Inc.
BIG
| $67K | 0.08% |
+37,500
| New | +$1.84M |
|
|
ATXS
128
DELISTED
Astria Therapeutics
ATXS
| $64K | 0.07% |
296
| – | – |
|
129
PUT
Cognizant
CTSH
$21.1B
| $64K | 0.07% |
+15,000
| New | +$803K |
|
|
DVAX
130
DELISTED
Dynavax Technologies
DVAX
| $62K | 0.07% |
15,581
-11,449
| -42% | -$83.9K |
|
|
131
CALL
Cognizant
CTSH
$21.1B
| $58K | 0.07% |
+31,100
| New | +$1.66M |
|
132
PUT
Accenture
ACN
$88.5B
| $55K | 0.06% |
14,900
-38,700
| -72% | -$4.59M |
|
133
CALL
Cigna
CI
$75.1B
| $55K | 0.06% |
23,000
-2,700
| -11% | -$353K |
|
|
134
PUT
Humana
HUM
$46.4B
| $54K | 0.06% |
35,900
+4,000
| +13% | +$763K |
|
|
FOLD
135
PUT
DELISTED
Amicus Therapeutics
FOLD
| $51K | 0.06% |
10,000
-15,000
| -60% | -$104K |
|
136
PUT
Coca-Cola
KO
$365B
| $50K | 0.06% |
35,000
+4,000
| +13% | +$166K |
|
|
XLNX
137
PUT
DELISTED
Xilinx Inc
XLNX
| $50K | 0.06% |
25,600
+24,400
| +2,033% | +$1.31M |
|
138
PUT
Starbucks
SBUX
$124B
| $49K | 0.06% |
32,500
| – | – |
|
|
AET
139
PUT
DELISTED
Aetna Inc
AET
| $48K | 0.06% |
+5,000
| New | +$599K |
|
|
FOLD
140
DELISTED
Amicus Therapeutics
FOLD
| $44K | 0.05% |
+8,792
| New | +$60.8K |
|
141
Alaunos Therapeutics
TCRT
$5.06M
| $44K | 0.05% |
54
-79
| -59% | -$71.2K |
|
|
ALR
142
CALL
DELISTED
Alere Inc
ALR
| $44K | 0.05% |
+9,500
| New | +$384K |
|
|
ICPT
143
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $43K | 0.05% |
+400
| New | +$47.7K |
|
|
ICPT
144
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $43K | 0.05% |
900
-12,000
| -93% | -$1.43M |
|
145
CALL
AbbVie
ABBV
$449B
| $42K | 0.05% |
73,844
+35,000
| +90% | +$2.14M |
|
146
PUT
Planet Fitness
PLNT
$4.18B
| $41K | 0.05% |
+65,000
| New | +$1.35M |
|
147
PUT
Domino's
DPZ
$11B
| $40K | 0.05% |
+10,000
| New | +$1.63M |
|
148
CALL
Sarepta Therapeutics
SRPT
$1.82B
| $40K | 0.05% |
106,200
-67,100
| -39% | -$2.69M |
|
149
PUT
Abbott
ABT
$172B
| $39K | 0.04% |
30,000
| – | – |
|
150
PUT
Hershey
HSY
$35.4B
| $39K | 0.04% |
6,000
+1,200
| +25% | +$118K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q4 2016 Portfolio in Review
As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
FT Options withdrew a net $42.6M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.
- FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
- FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
- FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
- FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
- FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
- FT Options opened 86 new positions and closed 202 in Q4 2016.
- FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.
Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.